An unusual case of 4-aminopyridine toxicity

被引:26
作者
Johnson, NC [1 ]
Morgan, MW [1 ]
机构
[1] Reg Hosp, Emergency Med Off, Dept Emergency Med, St Paul, MN 55101 USA
关键词
neuromuscullar disorders; 4-aminopyridine; toxicity;
D O I
10.1016/j.jemermed.2005.04.020
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
4-aminopyridine (4-AP) is an orphan drug in the United States. It enhances neuronal conduction at synapses and is indicated in the treatment of selected neuromuscular disorders, including multiple sclerosis and myasthenia gravis, among others. Its documented toxicity generally has been limited to central nervous system (CNS) hyperexcitation and gastrointestinal upset. In this case, a 56-year-old man accidentally overdosed on an unknown amount of generic 4-AP. This history was unknown by his family and unavailable to initial providers. Approximately I h after ingestion, his son found him diaphoretic, vomiting, and having unintelligible speech. In the ensuing 2-3 h, the patient became moderately hypothermic (32.8 degrees C; 91 degrees F), developed atrial fibrillation with a rapid ventricular response, and had neurological changes that were confused with an acute cerebrovascular accident. After a 36-h stay in the intensive care unit that included mechanical ventilation, cardioversion, passive rewarming, and an extensive medical workup, the patient recovered without sequelae. After extubation he stated that he thought he may have ingested too much 4-AP after rubbing a large amount of it against a sore tooth to take advantage of its local analgesic properties. This case of 4-AP overdose resulting in atrial fibrillation with rapid ventricular response, hypothermia, and acute neurological changes mistaken for an acute cerebrovascular accident is an unusual one. This case shows that overdose of 4-AP can cause or mimic several serious medical conditions, and that a detailed history and physical examination are essential for uncovering unusual diagnoses. (c) 2006 Elsevier Inc.
引用
收藏
页码:175 / 177
页数:3
相关论文
共 12 条
[1]  
HALA O, 2003, INT J BIOMAGNETISM, V5, P265
[2]  
PICKETT TA, 1995, ANN EMERG MED, V27, P383
[3]   4-AMINOPYRIDINE IN THE TREATMENT OF PATIENTS WITH MULTIPLE-SCLEROSIS - LONG-TERM EFFICACY AND SAFETY [J].
POLMAN, CH ;
BERTELSMANN, FW ;
VANLOENEN, AC ;
KOETSIER, JC .
ARCHIVES OF NEUROLOGY, 1994, 51 (03) :292-296
[4]  
Smeets J W, 1995, Ned Tijdschr Geneeskd, V139, P2667
[5]  
SOLARI A, 2004, COCHRANE LIB
[6]   4-AMINOPYRIDINE - A REVIEW [J].
SONI, N ;
KAM, P .
ANAESTHESIA AND INTENSIVE CARE, 1982, 10 (02) :120-126
[7]   POISONING WITH 4-AMINOPYRIDINE - REPORT OF 3 CASES [J].
SPYKER, DA ;
LYNCH, C ;
SHABANOWITZ, J ;
SINN, JA .
CLINICAL TOXICOLOGY, 1980, 16 (04) :487-497
[8]   CHARACTERIZATION OF 4-AMINOPYRIDINE IN OVERDOSE [J].
STORK, CM ;
HOFFMAN, RS .
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1994, 32 (05) :583-587
[9]   2 COMPONENTS OF TRANSIENT OUTWARD CURRENT IN CANINE VENTRICULAR MYOCYTES [J].
TSENG, GN ;
HOFFMAN, BF .
CIRCULATION RESEARCH, 1989, 64 (04) :633-647
[10]  
UGES DRA, 1984, PHARM ACTA HELV, V59, P172